Market Cap : 275.37 B | Enterprise Value : 283.5 B | PE Ratio : 9.59 | PB Ratio : 3.15 |
---|
NYSE:PFE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pfizer's revenue per share for the three months ended in Jun. 2022 was $4.86. Pfizer's revenue per share for the trailing twelve months (TTM) ended in Jun. 2022 was $17.62.
During the past 12 months, the average Revenue Per Share Growth Rate of Pfizer was 81.00% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 27.80% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 6.20% per year. During the past 10 years, the average Revenue Per Share Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Pfizer's Revenue per Share or its related term are showing as below:
During the past 13 years, Pfizer's highest 3-Year average Revenue Per Share Growth Rate was 27.80% per year. The lowest was -5.60% per year. And the median was 6.10% per year.
The historical data trend for Pfizer's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Pfizer's Revenue Per Share for the fiscal year that ended in Dec. 2021 is calculated as
Revenue Per Share (A: Dec. 2021 ) | = | Revenue (A: Dec. 2021 ) | / | Shares Outstanding (Diluted Average) (A: Dec. 2021 ) |
= | 81288 | / | 5708.000 | |
= | 14.24 |
Pfizer's Revenue Per Share for the quarter that ended in Jun. 2022 is calculated as
Revenue Per Share (Q: Jun. 2022 ) | = | Revenue (Q: Jun. 2022 ) | / | Shares Outstanding (Diluted Average) (Q: Jun. 2022 ) |
= | 27742 | / | 5712.000 | |
= | 4.86 |
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $17.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Thank you for viewing the detailed overview of Pfizer's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Denton David M | officer: Chief Financial Officer & EVP | 1000 LOWE'S BOULEVARD MOORESVILLE NC 28117 |
Pao William | officer: Executive Vice President | C/O CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Mcdermott Michael | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET 235 EAST 42ND STREET NY 10017 |
Malik Aamir | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Carapezzi William R Jr | officer: Executive Vice President | 600 MOUNTAIN AVENUE MURRAY HILL NJ 07921 |
Sahni Payal | officer: Executive Vice President | ATTN: PFIZER CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 |
Desmond-hellmann Susan | director | 513 PARNASSUS AVENUE S126 SAN FRANCISCO CA 94143 |
Hockfield Susan | director | GENERAL ELECTRIC COMPANY 41 FARNSWORTH STREET BOSTON MA 02210 |
Damico Jennifer B. | officer: SVP & Controller | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Quincey James | director | THE COCA-COLA COMPANY ONE COCA-COLA PLAZA ATLANTA GA 30313 |
Gottlieb Scott | director | MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142 |
Fonseca Lidia | officer: Executive Vice President | 358 SOUTH MAIN STREET BURLINGTON NC 27215 |
Goettler Michael | officer: Group President | 1000 MYLAN BOULEVARD CANONSBURG PA 15317 |
Rogers Dawn | officer: Executive Vice President | 235 EAST 42ND STREET NEW YORK NY 10017 |
Littman Dan R. | director | ATTN: CORPORATE SECRETARY PFIZER INC. 235 E. 42ND ST NEW YORK NY 10017 |
Other Sources
By Zacks 2022-03-23
By Zacks 2022-03-30
By Zacks 2022-03-28
By Zacks 2022-03-23
By Zacks 2022-03-25
By Zacks 2022-03-30
By Zacks 2022-03-24
By Zacks 2022-04-04
By Zacks 2022-04-01
By Fool 2022-04-05
By tipranks.com 2022-03-25
By Zacks 2022-04-04
By Zacks 2022-03-30